Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 248
Appendix H
Acronyms
AAPAA American Academy of Psychiatrists in Alcoholism and
Addiction
ABMS American Board of Medical Specialties
ABPN American Board of Psychiatry and Neurology
ACTH adrenocorticotrophic hormone
ADAMHA Alcohol, Drug Abuse, and Mental Health Administration
ADD Antiepileptic Drug Development Program
ADEPT Alcohol and Drug Education for Physician Training
AFDC Aid to Families with Dependent Children
AIDS acquired immune deficiency syndrome
ALS amyotrophic lateral sclerosis (Lou Gehrig's disease)
AMBHA American Managed Behavioral Healthcare Association
AMERSA Association for Medical Education and Research in
Substance Abuse
AMP adenosine 3'5'-monophosphate
ASAM American Society of Addiction Medicine
ATC addiction training center
AZT zidovudine
BDC BioDevelopment Corporation
BJS Bureau of Justice Statistics
BLS Bureau of Labor Statistics
BSMD Biobehavioral Sciences and Mental Disorders
CALDATA California Drug and Alcohol Treatment Assessment
CASA Center on Addiction and Substance Abuse
CBO Congressional Budget Office
248
OCR for page 249
APPENDIX H 249
CDC Centers for Disease Control and Prevention
CDDA Commission on Medicines for Treatment of Drug
Dependence and Abuse
CDER Center for Drug Evaluation and Research
CDP chemical dependency programs
CME continuing medical education
CMHS Center for Mental Health Services
CNS central nervous system
CPDD College on Problems of Drug Dependence
CRADAs cooperative research and development agreements
CRS Congressional Research Service
CSA Controlled Substances Act
CSAP Center for Substance Abuse Prevention
CSAT Center for Substance Abuse Treatment
CTDP Cocaine Treatment Discovery Program
DAWN Drug Abuse Warning Network
DD drug-discrimination test
DEA Drug Enforcement Agency
DHHS U.S. Department of Health and Human Services
DPC-PTR Drug Price Competition and Patent Term Restoration Act
DSRS Drug Services Research Survey
DVA Department of Veterans Affairs
FDA Food and Drug Administration
FDCA Federal Food, Drug, and Cosmetic Act
FTEs full-time equivalent personnel
FY fiscal year
GAO General Accounting Office
HIV human immunodeficiency virus
HMO health maintenance organization
HRSA Health Resources and Services Administration
IDU injecting drug-user
IND investigational new drug
IOM Institute of Medicine
IRE institutional review board
K20 Scientist Development Award for Clinicians
K21 Scientist Development Award
LAAM levo-alpha-acetylmethadol (trade name ORLAAM)
LMA locomotor-activity test
LRP Loan Repayment Program
MARC Minority Access to Research Careers
MDD Medications Development Division
MDMA Methylenedioxymethamphetamine ("ecstacy")
OCR for page 250
250 DEVELOPMENT OF MEDICATIONS
MSH melanocyte-stimulating hormone
NAS National Academy of Sciences
NASADAD National Association of State Alcohol and Drug Abuse
Directors, Inc.
NATA Narcotic Addict Treatment Act
NCDDG-AIDS National Cooperative Drug Discovery Groups on Acquired
Immune Deficiency Syndrome
NCI National Cancer Institute
NCJA National Criminal Justice Association
NDA new drug application
NDATUS National Drug and Alcoholism Treatment Survey
NIAAA National Institute on Alcohol Abuse and Alcoholism
Administration
NIAID National Institute of Allergy and Infectious Diseases
NIDA National Institute on Drug Abuse
NIH National Institutes of Health
NRC National Research Council
NRSA National Research Service Awards
ODE out-patient drug-free
ONDCP Office of National Drug Control Policy
OPRR Office of Protection from Research Risks
ORLAAMrM levo-alpha-acetylmethadol (LAAM)
OTA Office of Technology Assessment
PBMs pharmaceutical benefit managers
PCP phencyclidine
PhRMA Pharmaceutical Research and Manufacturers of America
PHS Public Health Service
PMA Pharmaceutical Manufacturers Association
POMC pro-opiomelanocortin
R&D research and development
R01 investigator-initiated grants
R18 research-demonstration grants
SA self-administration test
SADAP State Alcohol and Drug Abuse Profile
SAMHSA Substance Abuse and Mental Healtn Services Administration
SSI Supplemental Security Income
TB tuberculosis
Tcs therapeutic communities
TOPS Treatment Outcome Prospective Study
TRUs treatment research units
VA Department of Veterans Affairs
WHO World Health Organization
Representative terms from entire chapter:
drug abuse
